FDA issues rare notice of noncompliance for not reporting clinical trial results
In a rare move, the FDA issued a notice of noncompliance to an oncology company for failing to submit clinical data on its treatment for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
